Bath & Body Works, Inc. (BBWI)

NYSEConsumer DiscretionarySpecialty RetailSnapshot 2026-10-23

$20.95-3.01%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Bath & Body Works, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.5%

+10% or more+5%0%−5%−10% or less

2.77 → 2.75 EPS · FY ending Jan 31, 2028 · 12 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 12 to 12; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	—	1.55B
EPS	$0.05–$0.1non-GAAP	0.112
FY 2026 · Annual
Revenue	—	7.1B
EPS	$3.13–$3.33non-GAAP	2.691
Free cash flow	About $650M	—
FY 2027 · Annual
Revenue	—	7.21B
EPS	—	2.753

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash from operations increases to at least $244 million in Q1 2026	Cash from operations rose to $244 million in Q1 2026.	Intact	cash from operations falls below $188 million in any quarter after Q1 2026	Cash from operations: $72M FY2026-Q2; GAAP. Published target: >=244 million USD. Target period is not explicitly aligned with this observation. Source published Aug 26, 202672,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Maintain quarterly dividend payout at $0.20 per share	Bath & Body Works keeps steady dividend payouts at $0.20 per share.	Intact	dividend per share falls below $0.20 in any quarter of 2026	Dividend per share: $0.20 per share FY2026-Q2; GAAP. Published target: 0.20 USD per share quarterly. Target period is not explicitly aligned with this observation. Source published Aug 26, 20260.2 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 004ff0cd-375e-4235-80b5-c168bcedca8f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Generate approximately $600 million free cash flow in fiscal 2026	The company aims for $600 million free cash flow in 2026.	Intact	free cash flow falls below $500 million in FY2026	Free cash flow: $23M FY2026-Q2; GAAP. Published target: >=600 million USD. Target period is not explicitly aligned with this observation. Source published Aug 26, 202623,000,000 USD · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. Management maintains free cash flow guidance of approximately $600 million for fiscal 2026, with a slight increase to $650 million in 2026-Q3. Actual operating cash flow was $244 million in 2026-Q1 and $316 million year-to-date as of 2026-Q3, supporting the target. The trajectory shows consistent guidance with slight upward revision, indicating delivering progress. Delivery assessment Oct 24, 2026
Revenue remains near $7.3 billion in fiscal 2026	A primary condition in Bath & Body Works, Inc.'s published investment case. The stated target is >=7.29 billion USD.	Under Pressure	revenue falls below $7.0 billion in FY2026	Revenue: $1.514B FY2026-Q2; GAAP. Published target: >=7.29 billion USD. Target period is not explicitly aligned with this observation. Source published Aug 26, 20261,514,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Aug 1, 2026 Source: company_financial_results. Reference: 004ff0cd-375e-4235-80b5-c168bcedca8f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-01-31 · fmp

FY2028 EPS$2.75

$2.84 → $2.75 · observed estimates

FY2028 revenue$7.21B

$7.23B → $7.21B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$2.84	$7,226,744,873	11 / 13
2026-07-25	$2.84	$7,226,744,873	11 / 13
2026-07-26	$2.84	$7,226,744,873	11 / 13
2026-07-27	$2.84	$7,226,744,873	11 / 13
2026-07-28	$2.84	$7,226,744,873	11 / 13
2026-07-29	$2.84	$7,226,744,873	11 / 13
2026-07-30	$2.84	$7,227,804,873	11 / 13
2026-07-31	$2.84	$7,227,804,873	11 / 13
2026-08-01	$2.84	$7,227,804,873	11 / 13
2026-08-02	$2.84	$7,227,804,873	11 / 13
2026-08-03	$2.84	$7,227,804,873	11 / 13
2026-08-04	$2.84	$7,227,804,873	11 / 13
2026-08-05	$2.84	$7,227,804,873	11 / 13
2026-08-06	$2.84	$7,227,804,873	11 / 13
2026-08-07	$2.84	$7,227,804,873	11 / 13
2026-08-08	$2.84	$7,227,804,873	11 / 13
2026-08-09	$2.84	$7,227,804,873	11 / 13
2026-08-10	$2.84	$7,227,804,873	11 / 13
2026-08-11	$2.84	$7,227,804,873	11 / 13
2026-08-12	$2.84	$7,227,804,873	11 / 13
2026-08-13	$2.86	$7,231,178,110	18 / 16
2026-08-14	$2.84	$7,227,804,873	11 / 13
2026-08-15	$2.84	$7,227,804,873	11 / 13
2026-08-16	$2.84	$7,227,804,873	11 / 13
2026-08-17	$2.84	$7,227,804,873	11 / 13
2026-08-18	$2.84	$7,227,804,873	11 / 13
2026-08-19	$2.84	$7,227,804,873	11 / 13
2026-08-20	$2.84	$7,227,804,873	11 / 13
2026-08-21	$2.85	$7,230,508,373	11 / 13
2026-08-22	$2.85	$7,230,508,373	11 / 13
2026-08-23	$2.85	$7,230,508,373	11 / 13
2026-08-24	$2.85	$7,230,508,373	11 / 13
2026-08-25	$2.85	$7,230,490,920	11 / 13
2026-08-26	$2.85	$7,230,490,920	11 / 13
2026-08-27	$2.85	$7,230,490,920	11 / 13
2026-08-28	$2.85	$7,230,490,920	11 / 13
2026-08-29	$2.78	$7,215,871,132	11 / 13
2026-08-30	$2.78	$7,215,871,132	11 / 13
2026-08-31	$2.78	$7,215,871,132	11 / 13
2026-09-01	$2.78	$7,215,871,132	11 / 13
2026-09-02	$2.78	$7,215,871,132	11 / 13
2026-09-03	$2.78	$7,215,871,132	11 / 13
2026-09-04	$2.78	$7,215,871,132	11 / 13
2026-09-05	$2.78	$7,222,033,356	11 / 13
2026-09-06	$2.78	$7,222,033,356	11 / 13
2026-09-07	$2.78	$7,222,033,356	11 / 13
2026-09-08	$2.78	$7,222,033,356	11 / 13
2026-09-09	$2.77	$7,222,033,356	11 / 13
2026-09-10	$2.76	$7,221,823,886	11 / 13
2026-09-11	$2.76	$7,221,823,886	12 / 13
2026-09-12	$2.76	$7,221,823,886	12 / 14
2026-09-13	$2.77	$7,216,703,643	12 / 14
2026-09-14	$2.77	$7,216,703,643	12 / 14
2026-09-15	$2.77	$7,216,703,643	12 / 14
2026-09-16	$2.77	$7,216,703,643	12 / 14
2026-09-17	$2.77	$7,216,703,643	12 / 14
2026-09-18	$2.77	$7,216,703,643	12 / 14
2026-09-19	$2.77	$7,216,703,643	12 / 14
2026-09-20	$2.77	$7,216,703,643	12 / 14
2026-09-21	$2.77	$7,216,703,643	12 / 14
2026-09-22	$2.77	$7,216,703,643	12 / 14
2026-09-23	$2.77	$7,216,703,643	12 / 14
2026-09-24	$2.77	$7,216,703,643	12 / 14
2026-09-25	$2.77	$7,216,703,643	12 / 14
2026-09-26	$2.77	$7,216,703,643	12 / 14
2026-09-27	$2.77	$7,216,703,643	12 / 14
2026-09-28	$2.77	$7,216,703,643	12 / 14
2026-09-29	$2.77	$7,216,677,711	12 / 14
2026-09-30	$2.77	$7,216,677,711	12 / 14
2026-10-01	$2.77	$7,216,677,711	12 / 14
2026-10-02	$2.77	$7,216,677,711	12 / 14
2026-10-03	$2.77	$7,216,677,711	12 / 14
2026-10-04	$2.77	$7,216,677,711	12 / 14
2026-10-05	$2.77	$7,216,677,711	12 / 14
2026-10-06	$2.77	$7,216,677,711	12 / 14
2026-10-07	$2.77	$7,216,677,711	12 / 14
2026-10-08	$2.77	$7,216,677,711	12 / 14
2026-10-09	$2.77	$7,216,677,711	12 / 14
2026-10-10	$2.77	$7,216,677,711	12 / 14
2026-10-11	$2.77	$7,216,677,711	12 / 14
2026-10-12	$2.77	$7,216,677,711	12 / 14
2026-10-13	$2.77	$7,216,677,711	12 / 14
2026-10-14	$2.77	$7,216,677,711	12 / 14
2026-10-15	$2.77	$7,216,677,711	12 / 14
2026-10-16	$2.77	$7,216,677,711	12 / 14
2026-10-17	$2.77	$7,216,677,711	12 / 14
2026-10-18	$2.77	$7,216,677,711	12 / 14
2026-10-19	$2.77	$7,216,677,711	12 / 14
2026-10-20	$2.77	$7,217,065,211	12 / 14
2026-10-21	$2.75	$7,213,281,812	12 / 13
2026-10-22	$2.75	$7,213,281,812	12 / 13
2026-10-23	$2.75	$7,213,281,812	12 / 13
2026-10-24	$2.75	$7,213,281,812	12 / 13

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	4	13	0
2026-06-01	4	13	0
2026-07-01	4	14	1
2026-08-01	5	13	1
2026-09-01	5	13	1
2026-10-01	5	13	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 5 Buy / Strong Buy · 13 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash from operations increases to at least $244 million in Q1 2026Cash from operations: $72M
Maintain quarterly dividend payout at $0.20 per shareDividend per share: $0.20 per share
Generate approximately $600 million free cash flow in fiscal 2026Free cash flow: $23M
Revenue remains near $7.3 billion in fiscal 2026Published status: Under Pressure

Next proof point

Nov 19, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.3%Typical daily move · historical

Downside history

-44.4%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Bath & Body Works, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a consumer business with a transformation-led multi-year view, rather than a clear turnaround or steady compounder. The thesis is intact, but management’s transformation is still early and execution is mixed.

What's priced into Bath & Body Works, Inc.

The valuation evidence points to BBWI being cheap versus peers, while the priced-in tag says expectations are broadly justified and fragility is low. The expectations gap is slightly negative, but model confidence is low, so the valuation signal is uncertain.

What the fundamentals likely do

Recent financial performance is strong, with an earnings beat and reported early progress in the Consumer First Formula transformation. Sales have still declined in recent quarters, while cash flow guidance was maintained and then raised slightly; the near-term risk is erratic, weakening earnings surprises and a possible guidance cut.

What Bath & Body Works, Inc. hinges on

Over the next few quarters, the thesis depends on whether the transformation produces sustained improvement in sales and business execution. A guidance cut would be a meaningful negative, while continued strength among consumer-sector bellwethers could support sector momentum; weakness there could remove that support.